Pharma Mirror

AUGUST 28, 2021

SINGAPORE- Azelis, a leading innovative service provider in the specialty chemicals and food ingredients industry, is proud to publish its second sustainability report which covers the 2020 group-wide sustainability performance. Highlights & rationale– The report showcases Azelis’ environmental, social, and governance (ESG) commitments and reinforces its ambitions to become the world-leading provider of sustainable solutions and services– Azelis sustainability strategy, Act

Production 130

Production 130

ECRG Media's Clinical Research Podcast

AUGUST 28, 2021

Fake CRAs and How the Pandemic Impacted Sites Don't forget to Subscribe for new content! Merch: [link] Subscribe: [link] Email: eliteclinicalgroup@gmail.com Podcast: [link] [link] eliteclinicalgroup@gmail.com Watch: » Industry News: [link] All Videos: [link] Interview Recaps: [link] Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education Elite Clinical Research Group or ECRG for sho

Clinical Research 52

Clinical Research Research Production 52

Pharma Mirror

AUGUST 28, 2021

ADELAIDE- Agilex Biolabs, the Australian specialist bioanalytical and toxicology laboratory facilities for clinical trials is partnering with Endpoints News to share the latest on “Non-clinical and clinical pathways for rapid vaccine development in Australia”, in a webinar hosted by Endpoints News Editor Arsalan Arif. Agilex Biolabs’ Director, Immunoassay, Kurt J.

Vaccination 130

Vaccination Vaccine Development Clinical Trials 130

ECRG Media's Clinical Research Podcast

AUGUST 28, 2021

Fake CRAs and How the Pandemic Impacted Sites. Don't forget to Subscribe for new content! Merch: [link]. Subscribe: [link]. Email: eliteclinicalgroup@gmail.com. Podcast: [link] [link] eliteclinicalgroup@gmail.com Watch: » Industry News: [link] All Videos: [link] Interview Recaps: [link] Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education.

Clinical Research 52

Clinical Research Research Production 52

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Clinical Research

Pharma Mirror

AUGUST 28, 2021

SignalRx Pharmaceuticals Inc., Crystec Ltd., and ADYA Consulting SAGL are pleased toannounce a new collaboration to develop an inhaled dry powder formulation of SF2523 for the treatmentof pulmonary fibrosis, lung cancer and SARS-CoV-2 related illnesses. SignalRx SF2523 is a novel, small molecule dual PI3K-BRD4 inhibitor with a synergistic action on twopathways associated with the development of lung cancer and idiopathic pulmonary fibrosis (IPF).

Development 130

Development Marketing Drugs 130

Clinical Trial Gurus

AUGUST 28, 2021

Site selection visits in clinical research need to occur before every trial but it could be nerve wrecking for newer sites. In tis video I demystify this topic and tell clinical research site owners what they can expect.

Clinical Research 52

Clinical Research Research Trials 52

Drug Patent Watch

AUGUST 28, 2021

This chart shows the pharmaceutical companies with the most patents in Croatia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Croatia? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs 52

BioTech 365

AUGUST 28, 2021

Bayer Announces KERENDIA® (finerenone) Reduces the Risk of Cardiovascular Outcomes in New Phase III FIGARO-DKD Study in Adults With Chronic Kidney Disease (Stages 1-4) Associated With Type 2 Diabetes Bayer Announces KERENDIA® (finerenone) Reduces the Risk of Cardiovascular Outcomes in … Continue reading →

52

52